Orbits Oncology

Startup

Orbits Oncology offers a digital platform that enhances organoid analysis and helps biopharma identify the best cancer drug candidates to move into clinical trials. We build digital twins of cancer patients using data from patients, drugs, and advanced cancer models called organoids, which predict patient therapy response and identify biomarkers in early drug development. Using insights from our digital twins, we de-risk clinical translation of drug candidates. Our digital platform integrates into existing biopharma workflows using a platform-as-a-service model.

website